Abstract
Gallbladder papillary carcinoma is a less common form of gallbladder carcinoma that accounts for around 5% of all gallbladder malignancies. Because of its early manifestation and delayed invasion in the gallbladder wall, it has a better prognosis than adenocarcinoma. It is quite rare for it to manifest as cholecystocolic fistula. Imaging aids in the diagnosis of the lesion and associated fistula, as well as in determining the surgical extent of excision. Histology further aids in accurate diagnosis by recognizing the papillary architecture of the tumor as well as the extent of invasion. We herein present a case of a 51-year-old female who presented with symptoms of abdominal pain and vomiting for a month. Contrast-enhanced computed tomography showed thickened gallbladder wall with the presence of cholecystocolic fistula and enlarged pericholecystic lymph node. Cholecystectomy with excision of fistulous tract and lymph node was done, which showed gallbladder papillary carcinoma with metastasis to lymph node. After surgery, the patient received chemotherapy and was followed for 2 years with no symptoms of recurrence. To summarize, papillary gallbladder cancer is less prevalent and has a better prognosis than adenocarcinoma. Imaging and histology are critical in identifying the lesion and determining the best treatment option.
Similar content being viewed by others
Data Availability
All data published in article and information available in institute.
Code Availability
NA.
References
Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the GB Histologic types, stage of disease, grade, and survival rates. Cancer. 1992;70(6):1493–7.
Lazcano-Ponce EC, Miquel JF, Muñoz N, Herrero R, Ferrecio C, Wistuba II, Alonso de Ruiz P, AristiUrista G, Nervi F. Epidemiology and molecular pathology of GB cancer. CA Cancer J Clin. 2001;51(6):349–64.
Goldin RD, Roa JC. GB cancer: a morphological and molecular update. Histopathology. 2009;55(2):218–29.
Albores-Saavedra J, Tuck M, McLaren BK, Carrick KS, Henson DE. Papillary carcinomas of the GB: analysis of noninvasive and invasive types. Arch Pathol Lab Med. 2005;129(7):905–9.
Wang SJ, Fuller CD, Kim JS, Sittig DF, Thomas CR Jr, Ravdin PM. Prediction model for estimating the survival benefit of adjuvant radiotherapy for GB cancer. J Clin Oncol. 2008;26(13):2112–7.
Lee SS, Kim MH, Lee SK, Jang SJ, Song MH, Kim KP, Kim HJ, Seo DW, Song DE, Yu E, Lee SG, Min YI. Clinicopathologic review of 58 patients with biliary papillomatosis. Cancer. 2004;100(4):783–93.
Wan X, Zhang H, Chen C, Yang X, Wang A, Zhu C, Fu L, Miao R, He L, Yang H, Zhao H, Sang X. Clinicopathological features of GB papillary adenocarcinoma. Medicine (Baltimore). 2014;93(27): e131.
Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the GB. Lancet Oncol. 2003;4(3):167–76.
Albores-Saavedra J, Murakata L, Krueger JE, Henson DE. Noninvasive and minimally invasive papillary carcinomas of the extrahepatic bile ducts. Cancer. 2000;89(3):508–15.
Albores-Saavedra J, Henson DE, Klimstra D. Tumors of the GB, extrahepatic bile ducts, and ampulla of vater. Washington, DC: Armed Forces Institute of Pathology; 2000. Atlas of Tumor Pathology; 3rd series, fascicle 27. (1 of articles 4)
Hoang MP, Murakata LA, Katabi N, Henson DE, Albores-Saavedra J. Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases. Mod Pathol. 2002;15(12):1251–8.
Ha GW, Lee MR, Kim JH. Cholecystocolic fistula caused by gallbladder carcinoma: preoperatively misdiagnosed as hepatic colon carcinoma. World J Gastroenterol: WJG. 2015;21(15):4765.
Kuo JY, Jao YT. Gallbladder papillomatosis and cholecystocolonic fistula: a rare combination. Am J Case Rep. 2014;15:466.
Kang JS, Lee KB, Choi YJ, Byun Y, Han Y, Kim H, Kwon W, Jang JY. A comparison of outcomes in patients with intracholecystic papillary neoplasms or conventional adenocarcinomas of the gallbladder. HPB. 2021;23(5):746–52.
Wang Z, Wang L, Hua Y, Zhuang X, Bai Y, Wang H. Development and validation of a prognostic nomogram for gallbladder papillary adenocarcinoma. Front Oncol. 2023;16(13):1157057.
Author information
Authors and Affiliations
Contributions
Planning—PS
Conduct—PS, JNB
Reporting—PS, JNB
Concepts and design—JNB
Data acquisition—PS
Data Interpretation—JNB
Manuscript preparation, editing, and review—PS, JNB
Corresponding author
Ethics declarations
Ethics Approval
Waivers from Institute Ethics Committee.
Consent to Participate
Obtained from patient. The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given her consent for their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published, and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Consent for Publication
Written informed consent taken from patient.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Topical Collection on Surgery
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Saraf, P., Bharti, J.N. Gall Bladder Papillary Carcinoma Presenting as Cholecystocolic Fistula and Metastasizing to Pericholecystic Lymph Node: an Incidental and Rare Finding—a Case Report. SN Compr. Clin. Med. 5, 230 (2023). https://doi.org/10.1007/s42399-023-01571-4
Accepted:
Published:
DOI: https://doi.org/10.1007/s42399-023-01571-4